News
Changes in eating habits are impacting some categories, like snacks, more than others. Taking GLP-1 drugs reduces a person's appetite significantly, slowing down the emptying of the stomach and making ...
Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.
Historically, managing type 2 diabetes in advanced chronic kidney disease (CKD) has been challenging due to a lack of therapies and increased risks for adverse events.
Here’s a roundup of numbers from the last week of HR news — including the percentage of managers who use AI to help determine ...
This is only a glimpse of the data available to CivicScience clients. Discover more data. It’s safe to say that GLP-1 ...
DoseSpot, which delivers best-in-class e-prescribing, insurance verification and revenue cycle management solutions for healthcare providers, announced today the results of a new data analysis on 102, ...
A new study reveals that weight lost with GLP-1 drugs, such as semaglutide, is regained within a year after stopping ...
The rise of Ozempic and weight-loss drugs is a convenient excuse for the fashion industry and retailers to cut back on plus-size clothing options.
Stores of glucose in the brain could play a much more significant role in the pathological degeneration of neurons than ...
AFTER losing three stone on fat jabs, Emmie Barwise loved nothing more than picking out a stylish outfit to showcase her svelte new figure. However, there was one accessory she wasn’t ...
The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...
The GLP-1 drugs, including Mounjaro and Wegovy, work by mimicking the action of hormones that make you feel full, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results